Drugs / ATAC Therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01793025 | Sep 2012 → Dec 2018 | acute myeloid leukemia | Maisonneuve-Rosemont Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATAC Therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01793025 ↗ |
| Modality | Cell therapy | “The ATAC cell therapy product contains unselected, non-mobilized peripheral blood mononuclear cells” NCT01793025 ↗ |